Interests in associates - Reconciliation to carrying amounts (Net assets) (Details) - EUR (€) € in Thousands |
12 Months Ended | |||||
|---|---|---|---|---|---|---|
May 27, 2025 |
May 22, 2024 |
May 22, 2023 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Interests in associates | ||||||
| Profit for the period | € 1,191,267 | € 740,870 | € 732,458 | |||
| Other comprehensive income | (1,466,407) | 715,902 | (630,011) | |||
| Dividends paid | € (422,515) | € (349,162) | € (328,623) | (422,515) | (349,162) | (328,623) |
| Carrying amount | 663,652 | 620,831 | ||||
| Vifor Fresenius Medical Care Renal Pharma Ltd. | ||||||
| Interests in associates | ||||||
| Opening balance net assets (liabilities) January 1, | 918,335 | 893,505 | ||||
| Profit for the period | 456,306 | 290,766 | ||||
| Other comprehensive income | (3,428) | (116,914) | ||||
| Dividends paid | (304,832) | (205,301) | ||||
| Foreign currency translation | (112,047) | 56,279 | ||||
| Closing balance net assets (liabilities) December 31, | 954,334 | 918,335 | € 893,505 | |||
| Company's share in net assets | 429,450 | 413,251 | ||||
| Other reconciling items | 257,528 | 219,166 | ||||
| Eliminations | (54,952) | (51,444) | ||||
| Carrying amount | € 632,026 | € 580,973 | ||||
| X | ||||||||||
- Definition Represents the eliminations of amounts of associates. No definition available.
|
| X | ||||||||||
- Definition Foreign currency translation impact on net assets No definition available.
|
| X | ||||||||||
- Definition Represents the other reconciling items of associates. No definition available.
|
| X | ||||||||||
- Definition The amount of share in net assets of associates. No definition available.
|
| X | ||||||||||
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. No definition available.
|
| X | ||||||||||
- Definition The amount of dividends recognised as distributions to owners of the parent. [Refer: Parent [member]] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of investments in associates accounted for using the equity method. [Refer: Total for all associates [member]; Investments accounted for using equity method] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of assets less the amount of liabilities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|